u/heart_rate_bump
Resting HR up 6bpm on titration, back down at maintenance. n=1, tracked daily.
member · joined 30 Apr 2024
Comments — page 3 of 5
comment on why does nobody talk about triple agonist in c/retatrutide · 14 points · 5 months ago
Strongly agree. Heart rate escalation needs the actual data, not impressions.
comment on [Lab] 16th independent test on QSC, and the trend is the interesting part in c/retatrutide · 456 points · 6 months ago
Which trial arm and what was the n?
comment on small win: TRIUMPH stopped being a problem at week 5 in c/retatrutide · 61 points · 6 months ago
triple agonism plus glucagon is a different physiological state than GIP/GLP-1 dual
comment on the hazard ratio thing finally clicked for me and I want to write it down in c/trialwatch · 112 points · 6 months ago
the 24 week readout is different from the 32 week readout
comment on [Vendor] WXT order #14 — Germany, 27 days, no drama, receipts inside in c/glp1uk · 3 points · 6 months ago
private 10mg is private prescription in Denmark this month
comment on what changed for me between week 30 and week 79 in c/retatrutide · 5 points · 6 months ago
This is correct.
Disagree on that part. 98.1% and 97.6% on the same vial is normal.
comment on reading A1c threads from 2024 and half of it aged badly in c/bloodwork · 1 points · 7 months ago
What are your reference ranges?
comment on [Discussion] pharmacy is doing more work than we give it credit for in c/glp1uk · 4 points · 7 months ago
the Scottish pathway is different from the English one
comment on my hs-CRP moved and I cannot work out whether FLOW is why in c/trialwatch · 41 points · 7 months ago
Phase 2 or phase 3?
comment on [Results] 67 weeks, 16kg, and A1c was the hard part in c/bloodwork · 76 points · 7 months ago
Every time this gets posted it hits the front page and every time someone has to re-explain it.
comment on tried STEP for 14 weeks. here is what happened. in c/trialwatch · -1 points · 7 months ago
SURMOUNT-4 discontinuation arm showed regain. That is the reality of a chronic disease treatment, not a failure.
comment on [Results] 47 weeks, 46kg, and identity was the hard part in c/researchpeptides · 18 points · 8 months ago
What are you comparing it against though?
comment on am I the only one who found TB-500 harder than the injections in c/researchpeptides · 11 points · 8 months ago
Inter-lab variance on this kind of assay is routinely 1–2 points. Different column, different gradient, different integration.
comment on reading SURPASS threads from 2024 and half of it aged badly in c/trialwatch · 8 points · 8 months ago
This is correct. Discontinuation arms show the regain reality.
comment on the MASH question that gets asked weekly, answered properly in c/survodutide · 1 points · 8 months ago
MASH claims need the trial and the biopsy endpoint
comment on am I the only one who found triple agonist harder than the injections in c/retatrutide · 11 points · 9 months ago
Slight fix: the number was 97.6, not 97.9. Decimal point, but a fairly consequential one.
comment on [Lab] SGN survo — VendorInvestigate came back 99.0% against a claimed 99.1% in c/survodutide · 10 points · 9 months ago
rodent glucagon is investigation only
comment on [PSA] ALT is not what most of this community thinks it is in c/bloodwork · 39 points · 9 months ago
ALT is where the fatty-liver story shows up first
comment on week 91 check-in — 37kg down, early fullness manageable, one thing confusing me in c/trialwatch · 2 points · 10 months ago
SURMOUNT-4 discontinuation arm showed regain. That is the reality of a chronic disease treatment, not a failure.
comment on week 91 check-in — 37kg down, early fullness manageable, one thing confusing me in c/trialwatch · 1 points · 10 months ago
Disagree. What you are describing is consistent with STEP, not with what you concluded.